• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
RETRACTION: Combination of Aloin and Metformin Enhances the Antitumor Effect by Inhibiting the Growth and Invasion and Inducing Apoptosis and Autophagy in Hepatocellular Carcinoma Through PI3K/AKT/mTOR Pathway.撤回声明:芦荟素与二甲双胍联合通过PI3K/AKT/mTOR途径抑制肝癌细胞生长、侵袭并诱导凋亡和自噬从而增强抗肿瘤作用。
Cancer Med. 2024 Aug;13(15):e70055. doi: 10.1002/cam4.70055.
2
Retraction: Increased Six1 expression in macrophages promotes hepatocellular carcinoma growth and invasion by regulating MMP-9.撤稿声明:巨噬细胞中Six1表达增加通过调节MMP-9促进肝细胞癌的生长和侵袭。
J Cell Mol Med. 2024 Apr;28(7):e18249. doi: 10.1111/jcmm.18249.
3
Retraction.撤回。
Cancer Med. 2023 Dec;12(24):22437. doi: 10.1002/cam4.6773. Epub 2023 Dec 15.
4
Retraction: The long non-coding RNA-ROR promotes osteosarcoma progression by targeting miR-206.撤稿声明:长链非编码RNA-ROR通过靶向miR-206促进骨肉瘤进展。
J Cell Mol Med. 2024 Mar;28(6):e18199. doi: 10.1111/jcmm.18199.
5
RETRACTION: Long Noncoding RNA UFC1 is Activated by E2F1 and Exerts Oncogenic Properties by Functioning as a CeRNA of FOXP3.撤稿声明:长链非编码RNA UFC1被E2F1激活并通过作为FOXP3的竞争性内源RNA发挥致癌特性。
Cancer Med. 2024 Sep;13(18):e70150. doi: 10.1002/cam4.70150.
6
Retraction: miR-365 secreted from M2 Macrophage-derived extracellular vesicles promotes pancreatic ductal adenocarcinoma progression through the BTG2/FAK/AKT axis.撤回声明:M2巨噬细胞衍生的细胞外囊泡分泌的miR-365通过BTG2/FAK/AKT轴促进胰腺导管腺癌进展。
J Cell Mol Med. 2024 Feb;28(4):e18188. doi: 10.1111/jcmm.18188.
7
RETRACTION: Puerarin 6″-O-xyloside suppressed HCC via regulating proliferation, stemness, and apoptosis with inhibited PI3K/AKT/mTOR.撤回声明:葛根素6″-O-木糖苷通过抑制PI3K/AKT/mTOR调节增殖、干性和凋亡来抑制肝癌。
Cancer Med. 2024 Oct;13(19):e70301. doi: 10.1002/cam4.70301.
8
Retraction: miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer.撤回声明:在三阴性乳腺癌中,miR-655通过靶向Prrx1抑制上皮-间质转化。
J Cell Mol Med. 2024 Apr;28(8):e18314. doi: 10.1111/jcmm.18314.
9
Retraction: Silencing of Prrx1b suppresses cellular proliferation, migration, invasion and epithelial-mesenchymal transition in triple-negative breast cancer.撤回声明:沉默Prrx1b可抑制三阴性乳腺癌细胞的增殖、迁移、侵袭及上皮-间质转化。
J Cell Mol Med. 2024 Apr;28(8):e18312. doi: 10.1111/jcmm.18312.
10
RETRACTION: MCCK1 enhances the anticancer effect of temozolomide in attenuating the invasion, migration and epithelial-mesenchymal transition of glioblastoma cells in vitro and in vivo.撤回声明:MCCK1增强替莫唑胺在体外和体内减弱胶质母细胞瘤细胞侵袭、迁移及上皮-间质转化方面的抗癌作用。
Cancer Med. 2024 Oct;13(19):e70300. doi: 10.1002/cam4.70300.

撤回声明:芦荟素与二甲双胍联合通过PI3K/AKT/mTOR途径抑制肝癌细胞生长、侵袭并诱导凋亡和自噬从而增强抗肿瘤作用。

RETRACTION: Combination of Aloin and Metformin Enhances the Antitumor Effect by Inhibiting the Growth and Invasion and Inducing Apoptosis and Autophagy in Hepatocellular Carcinoma Through PI3K/AKT/mTOR Pathway.

出版信息

Cancer Med. 2024 Aug;13(15):e70055. doi: 10.1002/cam4.70055.

DOI:10.1002/cam4.70055
PMID:39140463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11322991/
Abstract

R. Sun, R. Zhai, C. Ma, and W. Miao, "Combination of Aloin and Metformin Enhances the Antitumor Effect by Inhibiting the Growth and Invasion and Inducing Apoptosis and Autophagy in Hepatocellular Carcinoma Through PI3K/AKT/mTOR Pathway," Cancer Medicine 9, no. 3 (2020): 1141-1151, https://doi.org/10.1002/cam4.2723. The above article, published online on 12 December 2019 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors; the journal Editor-in-Chief, Stephen Tait; and John Wiley and Sons Ltd. The authors asked to retract the article as they found significant errors in the data collection and analysis, therefore the conclusions of the paper are not supported. Subsequently, an investigation into concerns raised by a third party revealed inappropriate duplication of images (Figure 1C, 2B and 4C, D) between this and other articles that were previously published or published shortly after in a different scientific context. Thus, the editors consider the conclusions of this manuscript substantially compromised. Although the authors initially asked for the retraction, when asked to approve the retraction wording, they remained unresponsive.

摘要

孙R、翟R、马C和苗W,“芦荟素与二甲双胍联合通过PI3K/AKT/mTOR途径抑制肝癌细胞生长、侵袭并诱导凋亡和自噬增强抗肿瘤作用”,《癌症医学》9卷,第3期(2020年):1141 - 1151页,https://doi.org/10.1002/cam4.2723 。上述文章于2019年12月12日在线发表于威利在线图书馆(wileyonlinelibrary.com),已根据作者、期刊主编斯蒂芬·泰特以及约翰·威利父子有限公司的协议撤回。作者要求撤回该文章,因为他们发现数据收集和分析存在重大错误,因此论文结论不成立。随后,对第三方提出的问题进行调查发现,本文与之前发表或之后不久在不同科学背景下发表的其他文章之间存在不适当的图像重复(图1C、2B和4C、D)。因此,编辑认为该手稿的结论受到严重影响。尽管作者最初要求撤回,但在要求他们批准撤回措辞时,他们没有回应。